Microbot Medical (NASDAQ:MBOT) Share Price Passes Above 200 Day Moving Average – What’s Next?

Microbot Medical Inc. (NASDAQ:MBOT)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.26 and traded as high as $1.54. Microbot Medical shares last traded at $1.44, with a volume of 469,348 shares changing hands.

Analyst Ratings Changes

Separately, HC Wainwright upped their price target on Microbot Medical from $7.00 to $9.00 and gave the company a “buy” rating in a report on Friday, January 24th.

Microbot Medical Stock Up 6.9 %

The business has a fifty day simple moving average of $1.81 and a two-hundred day simple moving average of $1.27. The company has a market cap of $53.51 million, a P/E ratio of -1.92 and a beta of 1.60.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Microbot Medical stock. Renaissance Technologies LLC bought a new stake in Microbot Medical Inc. (NASDAQ:MBOT) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 105,658 shares of the biotechnology company’s stock, valued at approximately $118,000. Renaissance Technologies LLC owned 0.52% of Microbot Medical as of its most recent filing with the Securities & Exchange Commission. 16.30% of the stock is owned by institutional investors and hedge funds.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.